Search the Newsreel

Smith & Nephew GAAP EPS of $0.36, revenue of $1.6B

* Smith & Nephew press release [https://seekingalpha.com/filing/309951347] (SNN [https://seekingalpha.com/symbol/SNN]): Q2 GAAP EPS of $0.36. * Revenue of $1.6B (+3.2% Y/Y). * Trading profit for the first half reached $566M, an 8.10% increase year-over-year, expanding the trading profit margin by 60 bps to 18.30%. * …

Smith+Nephew (SNN) lifts H1 2026 profit but cuts revenue growth outlook

Smith+Nephew reported a higher profit for the first half of 2026, with revenue reaching $3,097 million, an increase of 4.6% year-on-year, and trading profit up 8.1% to $566 million. Despite this profit growth, the company revised its full-year underlying revenue growth guidance downwards from …

Smith & Nephew SNATS, Inc. $SNN Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 12.5% in the first quarter, selling 176,622 shares but still retaining over 1.2 million shares valued at approximately $39.4 million. Despite this sale, several other institutional investors increased …

Smith & Nephew (SNN): executive share awards vest, partial sale to cover tax

Smith & Nephew plc reported that performance share awards granted in 2023 to Rohit Kashyap, President of Advanced Wound Management and Global Commercial Operations, vested on August 12, 2026. Of the 23,202 ordinary shares that vested, 9,163 were sold to cover tax liabilities, with …

REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & Nephew Plc has announced transactions made by Persons Discharging Managerial Responsibilities (PDMRs) and closely associated persons following the vesting of awards under its Global Share Plan 2020 and Restricted Share Plan 2024. The announcement details the vesting of 2023 Performance Share Awards, …

Cevian increases Smith & Nephew (NYSE: SNN) holding to 14.21% of votes

Cevian Capital II G.P. Limited has increased its aggregate holding in Smith & Nephew plc to 14.214414% of voting rights, corresponding to 119,179,419 shares. This represents a slight increase from its previously notified holding of 14.010786%, with the additional shares held through Cevian Capital …

REG - Smith & Nephew Plc - Holding(s) in Company

Cevian Capital II GP Limited has notified a change in its major holdings in Smith & Nephew Plc, with its total voting rights now at 14.214414%. This increase is primarily due to an increased stake via Cevian Capital II Master Fund L.P., though the …

Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript

Smith & Nephew SNATS, Inc. (SNN) Stock Forecasts

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Healthcare Innovator with a 12.53% Upside Potential

Smith & Nephew SNATS, Inc. (SNN) is a healthcare innovator with a robust market presence and promising growth potential, offering a 12.53% upside potential based on analyst ratings. The company boasts strong financial health with over $1 billion in free cash flow, 4.60% revenue …

Smith & Nephew SNATS Q2 Earnings Call Highlights

Smith & Nephew Is Under Pressure from External Factors and Portfolio Gaps

Smith & Nephew (SNN) is facing pressure due to external factors and gaps in its product portfolio, despite its history of innovation in orthopedics, sports medicine, and wound care markets. The company has shown strength in introducing innovations like Oxinium technology for hip replacements …

Smith & Nephew Earnings: Weakness in First Half Could Linger in Second Half

JPMorgan cuts Smith & Nephew stock rating on market slowdown

JPMorgan downgraded Smith & Nephew PLC to Neutral from Overweight, citing a slowdown in the orthopaedics market and the company's loss of market share in knees and hips. The firm also lowered its price target to GBP12.90 from GBP14.38 and expressed skepticism about the …

Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week

Smith+Nephew, the official Joint Replacement and Sports Medicine Technology Partner of the Pro Football Hall of Fame, is celebrating mobility, recovery, and football traditions during the 2026 Pro Football Hall of Fame Enshrinement Week in Canton, Ohio. The company will host an interactive booth …

Smith+Nephew Cuts 2026 Outlook Amid Orthopedics Decline

Smith+Nephew has lowered its full-year 2026 revenue guidance from 6% to 4% due to a disappointing Q2, with revenue growing only 1.6% and orthopedics experiencing a decline. Despite this, the company is maintaining its profit guidance by implementing additional efficiency savings from its 12-Point …

Smith & Nephew Delivers Strong H1 2026 Profit but Cuts Full-Year Revenue Outlook

Higher profit but softer sales at Smith+Nephew (NYSE: SNN)

Smith+Nephew reported higher H1 2026 profits, with trading profit increasing to $566 million and adjusted EPS rising 11.0% to 47.7¢, driven by efficiency savings. However, the company trimmed its full-year revenue growth outlook from around 6% to 4% due to softer sales in Orthopaedics …

REG - Smith & Nephew Plc - Half-Year Report

Smith+Nephew announced its Q2 and H1 2026 results, reporting strong H1 profit growth despite softer revenue growth. The company reaffirmed its full-year guidance for trading profit, free cash flow, and adjusted ROIC, even as it reduced its full-year revenue growth outlook from approximately 6% …

Smith & Nephew plc Provides Earnings Guidance for the Second Half of 2026

Smith & Nephew plc has issued earnings guidance for the second half of 2026, projecting a revenue growth rate between 5.0% and 5.5%. This forecast represents an increase in growth compared to the first half of the year. The announcement was made on August …

Smith & Nephew SNATS (NYSE:SNN) Announces Quarterly Earnings Results, Misses Estimates By $0.46 EPS

Earnings call transcript: Smith & Nephew Q2 2026 revenue miss weighs on shares

Smith & Nephew (SNN) reported Q2 2026 earnings with underlying revenue growth of 1.6%, below expectations due to softness in U.S. Orthopaedics and Advanced Wound Bioactives. Despite a revised full-year revenue outlook to around 4%, the company maintained its profit and cash flow guidance, …

Smith+Nephew (NYSE: SNN) trims 2026 growth to 4% but keeps profit goals

Smith+Nephew has revised its full-year 2026 underlying revenue growth forecast down to around 4% from an earlier estimate of 6%, attributed to softer-than-expected first-half growth and pressures in US Orthopaedics and Advanced Wound Bioactives. Despite this reduction in revenue outlook, the company maintains its …

Why Is Smith & Nephew (LSE:SN) Facing Fresh Market Attention?

Smith & Nephew Lowers Sales Growth Forecast Following Softer Second Quarter

Smith & Nephew has reduced its full-year revenue growth forecast after a weaker-than-expected second quarter, impacted by lower U.S. knee implant sales and changes in wound care reimbursement rules. Despite this, the company maintained its profit growth and free cash flow guidance due to …

Smith & Nephew cuts sales outlook after weak US trading

Smith & Nephew has lowered its full-year revenue growth forecast to approximately 4% due to weaker-than-anticipated performance in its US orthopaedics and wound care businesses during the second quarter. Despite this, the company maintained its guidance for trading profit, free cash flow, and return …

Smith & Nephew SNATS (NYSE:SNN) Trading Down 5.8% on Disappointing Earnings

Smith & Nephew plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:SNN) 2026-08-04

Smith & Nephew H1 Profit Rises

(RTTNews) - Smith & Nephew Plc (SNN, SN.L) reported that its first half profit before tax totaled $380 million compared to $362 million, a year ago. For the half year ended June 27, 2026, attributable profit was $303 million compared to $293 million in …

Smith & Nephew (NYSE: SNN) details 839.9M voting shares and treasury stock

Smith & Nephew plc has updated its voting share capital as of July 31, 2026, comprising 839,857,161 ordinary shares with voting rights. This figure excludes 37,876,589 treasury shares from its total issued share capital of 877,733,750 shares. Shareholders are instructed to use the voting …

Nano Dimension and 4 More Stocks See Action From Activist Investors

Activists also report to the SEC on Smith & Nephew, Navigator Holdings, Global Net Lease, and Radcom. Continue Reading

Smith & Nephew Expands Wound Care Portfolio in $22B Market

Smith & Nephew (SNN) is expanding its wound care portfolio and addressing the chronic wound management market, which is projected to grow to over $30 billion by 2030. The company recently launched two new innovations, ALLEVYN COMPLETE CARE Foam Dressing and RENASYS EDGE Negative …

Smith & Nephew PLC (SNN) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Smith & Nephew PLC (SNN), highlighting its current valuation score and P/E ratio. The company's valuation score is 5.83, ranking it 190 out of 199 in the Healthcare Equipment & Supplies industry. While the P/E ratio is …